Literature DB >> 22862558

Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications.

Tian-Tian Zhang1, Jian-Guo Jiang.   

Abstract

INTRODUCTION: Diabetes mellitus (DM) is a chronic progressive systemic disease caused by metabolic disorder. In recent years, significant amounts of studies have shown that traditional Chinese medicine (TCM) and its active ingredients have obvious hypoglycemic effect. AREAS COVERED: This paper summarizes single herbs and their active ingredients from TCM with the role of treating DM, and relevant literatures published in the past decades are reviewed. The active ingredients are divided into polysaccharides, saponins, alkaloids, flavonoids, terpenoids and others, which are described in this article from the aspects of active ingredients, sources, models, efficacy, and mechanisms. EXPERT OPINION: Mechanisms of TCM in treating DM are concluded: i) to promote insulin secretion and increase serum insulin levels; ii) to increase the sensitivity of insulin and improve its resistance; iii) to inhibit glucose absorption; iv) to affect glucose metabolism of insulin receptor; and v) to scavenge radicals and prevent lipid peroxidation. The separation and extraction of effective monomer from TCM is an important direction of anti-diabetic drug discovery currently. Future research about hypoglycemic mechanism of TCM based on the clinical should combine with modern scientific methods and regulatory approach to strive for more meaningful discovery and innovation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862558     DOI: 10.1517/13543784.2012.713937

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  25 in total

1.  Identification of natural products with neuronal and metabolic benefits through autophagy induction.

Authors:  Yuying Fan; Nan Wang; Altea Rocchi; Weiran Zhang; Robert Vassar; Yifa Zhou; Congcong He
Journal:  Autophagy       Date:  2016-10-28       Impact factor: 16.016

2.  Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways.

Authors:  Hongtao Tan; Junxian Chen; Yicong Li; Yingshan Li; Yunchang Zhong; Guangzhao Li; Lingling Liu; Yiqun Li
Journal:  Mol Med       Date:  2022-05-20       Impact factor: 6.376

Review 3.  Ancient records and modern research on the mechanisms of chinese herbal medicines in the treatment of diabetes mellitus.

Authors:  Hai-Ming Zhang; Feng-Xia Liang; Rui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

4.  Therapeutic Effects of Bupleurum Polysaccharides in Streptozotocin Induced Diabetic Mice.

Authors:  Lingyu Pan; Hongbo Weng; Hong Li; Zhenzhen Liu; Yanyan Xu; Chunjiao Zhou; Xiaoxiao Lu; Xiaoyu Su; Yunyi Zhang; Daofeng Chen
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

5.  Orthologs of human disease associated genes and RNAi analysis of silencing insulin receptor gene in Bombyx mori.

Authors:  Zan Zhang; Xiaolu Teng; Maohua Chen; Fei Li
Journal:  Int J Mol Sci       Date:  2014-10-09       Impact factor: 5.923

Review 6.  Clinical potentials of ginseng polysaccharide for treating gestational diabetes mellitus.

Authors:  Xuan-Yin Zhao; Fang Zhang; Wei Pan; Yi-Fang Yang; Xiao-Ya Jiang
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

Review 7.  Protective Effects and Network Analysis of Ginsenoside Rb1 Against Cerebral Ischemia Injury: A Pharmacological Review.

Authors:  Weijie Xie; Xinyue Wang; Tianbao Xiao; Yibo Cao; Yumei Wu; Dongsheng Yang; Song Zhang
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

8.  A Drug-Target Network-Based Approach to Evaluate the Efficacy of Medicinal Plants for Type II Diabetes Mellitus.

Authors:  Jiangyong Gu; Lirong Chen; Gu Yuan; Xiaojie Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-10       Impact factor: 2.629

9.  Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Miao Hu; Weiwei Zeng; Brian Tomlinson
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-16       Impact factor: 2.629

10.  Antidiabetic and antioxidative effect of jiang tang xiao ke granule in high-fat diet and low-dose streptozotocin induced diabetic rats.

Authors:  Dan-Dan Zhao; Na Yu; Xiao-Ke Li; Xin Fang; Qian-Qian Mu; Pei-Jie Qin; Yue Ma; Fang-Fang Mo; Dong-Wei Zhang; Si-Hua Gao
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.